Will you have Complex regional pain syndrome with Copaxone - from FDA reports
Complex regional pain syndrome is reported only by a few people who take Copaxone. We study 41,238 people who have side effects while taking Copaxone from FDA. Among them, 3 have Complex regional pain syndrome. Find out below who they are, when they have Complex regional pain syndrome and more.
eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.
eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.
How we gather our data?
Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.
The information that eHealthMe collects includes:
- Side effects (including severity and how people recover from them)
- Associated conditions or symptoms
- Drug effectiveness
- Demographic data regarding drug use
How the study uses the data?
The study is based on glatiramer acetate (the active ingredients of Copaxone) and Copaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Complex regional pain syndrome are also considered in the study.
What is Copaxone?
Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. (latest outcomes from Copaxone 41,766 users)
What is Complex regional pain syndrome?
Complex regional pain syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)) has been reported by people with pain, osteoporosis, complex regional pain syndrome, depression, rheumatoid arthritis (latest reports from 3,913 Complex regional pain syndrome patients).
How to use the study?
Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.
41,238 people reported to have side effects when taking Copaxone.
Among them, 3 people (0.01%) have Complex regional pain syndrome
Number of reports submitted per year:
Gender of people who have Complex regional pain syndrome when taking Copaxone *:
- female: 100 %
- male: 0.0 %
Age of people who have Complex regional pain syndrome when taking Copaxone *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 33.33 %
- 40-49: 66.67 %
- 50-59: 0.0 %
- 60+: 0.0 %
Top co-used drugs for these people *:
- Zanaflex: 2 people, 66.67%
- Diovan: 2 people, 66.67%
- Ambien Cr: 2 people, 66.67%
- Cymbalta: 2 people, 66.67%
- Cytomel: 2 people, 66.67%
- Mirapex: 2 people, 66.67%
- Marinol: 2 people, 66.67%
- Vytorin: 2 people, 66.67%
- Lasix: 2 people, 66.67%
- Coq10: 1 person, 33.33%
Top other side effects for these people *:
- Gait Disturbance: 3 people, 100.00%
- Fatigue (feeling of tiredness): 3 people, 100.00%
- Pain In Extremity: 3 people, 100.00%
- Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 66.67%
- Heart Rate Increased: 2 people, 66.67%
- Hyperaesthesia: 2 people, 66.67%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 66.67%
- Erythromelalgia (episodes of pain, redness, and swelling in various parts of the body): 2 people, 66.67%
- Drug Ineffective: 2 people, 66.67%
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 2 people, 66.67%
* Approximation only. Some reports may have incomplete information.
Do you have Complex regional pain syndrome while taking Copaxone?
- Check whether a drug or a condition causes Complex regional pain syndrome
- Subscribe to monitor Complex regional pain syndrome in Copaxone
- Subscribe to monitor Copaxone
You are not alone:
- Connect with people like you who take Copaxone and have Complex regional pain syndrome
- Use your healthcare experience to help people like you, and be rewarded
Related publications that referenced our studies
- Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
Drugs that are associated with Complex regional pain syndromeComplex regional pain syndrome (713 drugs)
Could your condition cause Complex regional pain syndromeComplex regional pain syndrome (454 conditions)
Copaxone side effects
- Copaxone side effects (41,247 reports)
Browse side effects by gender and age
Browse all side effects of Copaxonea b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Copaxone with similar drugs
- Copaxone vs. Amantadine hydrochloride
- Copaxone vs. Amitriptyline hydrochloride
- Copaxone vs. Ampyra
- Copaxone vs. Aricept
- Copaxone vs. Aubagio
- Copaxone vs. Avonex
- Copaxone vs. Azathioprine
- Copaxone vs. Baclofen
- Copaxone vs. Betaseron
- Copaxone vs. Carbamazepine
- Copaxone vs. Celexa
- Copaxone vs. Cellcept
- Copaxone vs. Clonazepam
- Copaxone vs. Cymbalta
- Copaxone vs. Diazepam
- Copaxone vs. Elavil
- Copaxone vs. Extavia
- Copaxone vs. Gabapentin
- Copaxone vs. Gilenya
- Copaxone vs. Ibuprofen
- Copaxone vs. Klonopin
- Copaxone vs. Lioresal
- Copaxone vs. Lyrica
- Copaxone vs. Modafinil
- Copaxone vs. Naltrexone hydrochloride
- Copaxone vs. Neurontin
- Copaxone vs. Novantrone
- Copaxone vs. Nuvigil
- Copaxone vs. Oxybutynin chloride
- Copaxone vs. Oxycontin
- Copaxone vs. Prednisone
- Copaxone vs. Pregabalin
- Copaxone vs. Provigil
- Copaxone vs. Prozac
- Copaxone vs. Rebif
- Copaxone vs. Rituxan
- Copaxone vs. Solu-medrol
- Copaxone vs. Soma
- Copaxone vs. Tecfidera
- Copaxone vs. Tizanidine hydrochloride
- Copaxone vs. Topamax
- Copaxone vs. Tramadol hydrochloride
- Copaxone vs. Tysabri
- Copaxone vs. Valium
- Copaxone vs. Vitamin d
- Copaxone vs. Xanax
- Copaxone vs. Zanaflex
- Copaxone vs. Zoloft
What would happen?
FDA reports used in this study
- Want to find out more about the FDA reports used in the study? You can request them from FDA.
Recent general studies
- Will you have Early Satiety with Levaquin? - now
- Will you have Abdominal Fullness Prematurely After Meals with Levaquin? - now
- Will you have Rickets Familial Hypophosphataemic with Marijuana? - a second ago
- Will you have Inguinal Mass with Crohn'S Disease? - 3 seconds ago
- Will you have Placenta Abruptio with Naproxen? - 7 seconds ago
- Will you have H2 Receptor Antagonists Poisoning with Tramadol? - 7 seconds ago
- Will you have Amyotrophic Lateral Sclerosis with Psoriasis? - 8 seconds ago
- Will you have Lou Gehrig'S Disease with Psoriasis? - 8 seconds ago
- Limbitrol vs. Tofranil - 8 seconds ago
- Will you have Als with Psoriasis? - 8 seconds ago
Recent personal studies
- Prediction of Ativan for a 46 year old woman - 37 minutes ago
- A study for a 62 year old woman who takes Labetalol Hydrocloride - an hour ago
- Drug comparison of Prednisolone Acetate, Azithromycin, Omeprazole for a 53 year old woman - 4 hours ago
- A study for a 73 year old woman who takes Vitamin B12 - 4 hours ago
- Prediction of Depakote for a 36 year old man - 4 hours ago
- A study for a 52 year old woman who takes Lisinopril - 6 hours ago
- A study for a 68 year old woman who takes Benlysta, Plaquenil, Cellcept - 10 hours ago
- A study for a 50 year old man who takes Symbicort, Singulair - 17 hours ago
- A study for a 39 year old man who takes Buprenorphine Hydrochloride; Naloxone Hydrochloride - 18 hours ago
- A study for a 72 year old woman who takes Oxybutynin Chloride - 18 hours ago
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.